NICE approves routine NHS use of CAR-T for diffuse large B-cell lymphoma

Lancet Oncol. 2023 Mar;24(3):208. doi: 10.1016/S1470-2045(23)00054-2. Epub 2023 Feb 2.
No abstract available

Publication types

  • News

MeSH terms

  • Humans
  • Immunotherapy, Adoptive / adverse effects
  • Lymphoma, Large B-Cell, Diffuse* / drug therapy
  • Lymphoma, Large B-Cell, Diffuse* / pathology
  • Receptors, Chimeric Antigen*
  • State Medicine

Substances

  • Receptors, Chimeric Antigen